Good morning. Thirty-three days. That’s how long it took from the time AstraZeneca CEO Pascal Soriot greeted Virginia Governor Glenn Youngkin in his London office to announcing a $4 billion ...

With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...

Soriot’s latest remarks came as the CEO trumpeted a “very encouraging” start to 2023. The drugmaker delivered total revenues of around $10.9 billion over the first three months of the year ...

CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention. Historic Summer Setup: 3 "Power Patterns" Triggering in the ...

AstraZeneca chief executive Pascal Soriot also told the Sunday Times that researchers developing its vaccine have figured out a “winning formula” making the jab as effective as rival candidates.

AstraZeneca’s boss Pascal Soriot was winning plaudits for his stewardship when the Covid-19 pandemic struck. Since then, he’s been having a hard time of it.

LONDON—Is AstraZeneca PLC Chief Executive Pascal Soriot staying or going? Shares in the U.K.-based drug giant fell sharply Thursday after a news outlet in Israel reported late Wednesday he was ...

This morning in New York, new AstraZeneca chief executive Pascal Soriot is telling investors how he is going to turn around the company that has had the absolute worst track record in research and ...

AstraZeneca PLC (NASDAQ: AZN) Q1 2020 Earnings Conference Call April 29, 2020 6:45 AM ET Company Participants Pascal Soriot - Chief Executive Officer Dave Fredrikson - Executive Vice President ...